Megs Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.30 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.80 M
- Revenue Growth 46.43%
- Profit Growth 51.14%
- Ebitda 65.88%
- Net Worth 9.51%
- Total Assets 33.56%
About Megs Pharmaceutical
Megs Pharmaceutical Limited (MPL) is a Public Limited Indian Non-Government Company incorporated in India on 03 August 2017 (Seven years and six months 2 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹3.80 M.
Ray Singh, Vrishdev Singh, and Vijendra Rathore serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999RJ2017PLC058722
-
Company No.
058722
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
03 Aug 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
What products or services does Megs Pharmaceutical Limited offer?
Megs Pharmaceutical Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Health Care Service, Gynecology Consultants, Medical Surgery & Treatment Centres, Medical Treatment Services, Pediatric Care Facilities, Common Disease Medicines, Pharmaceutical Tablets, Ayurvedic,Herbal Products & Medicine.
Who are the key members and board of directors at Megs Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ray Singh
|
Director | 03-Aug-2017 | Current |
|
Vrishdev Singh
|
Whole-Time Director | 03-Aug-2017 | Current |
|
Vijendra Rathore
|
Director | 26-Jan-2020 | Current |
Financial Performance of Megs Pharmaceutical.
Megs Pharmaceutical Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.43% increase. The company also saw a substantial improvement in profitability, with a 51.14% increase in profit. The company's net worth moved up by a moderate rise of 9.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Megs Pharmaceutical?
Unlock access to Megs Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Yolo Dynamics LimitedVrishdev Singh is a mutual person
Charges (Loans)
₹3.80 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.38 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Dec 2023 | Others | ₹2.50 M | Open |
| 31 Jan 2022 | Others | ₹0.20 M | Open |
| 01 Sep 2021 | Others | ₹1.00 M | Open |
| 01 Sep 2021 | Others | ₹0.10 M | Open |
How Many Employees Work at Megs Pharmaceutical?
Unlock and access historical data on people associated with Megs Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Megs Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Megs Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
